Cinemark Holdings, Inc.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
Cavalier Michael (EVP-General Counsel) sold (to issuer) 107,296 indirectly-held shares of Cinemark Holdings, Inc. (CNK) at $35.02 ($3.76M total) on 2026-09-01 under a Rule 10b5-1 trading plan.
Cinemark (CNK) officer Michael Cavalier plans to sell 107,296 shares, valued at $3.8M, via the Cavalier Revocable Trust. The shares stem from equity awards granted between 2014 and 2025, according to a Rule 144 notice. Cinemark has 115.9M shares outstanding as of September 1, 2026.
Cinemark Holdings (CNK) reported record box office results for Spider-Man: Brand New Day, with strong premium format and in-theater spending. The company's stock has seen recent declines but remains up 17.61% over 90 days and 41.20% over one year. Analysts estimate CNK is 6.2% undervalued, with a fair value of $38.36, citing strong consumer demand and a robust film release pipeline.
Over the past 7 days, alphai's AI scored 2 news stories mentioning CNK (Cinemark Holdings, Inc.). Coverage has been balanced: 0 bullish, 2 neutral, and 0 bearish.
Recent CNK coverage spans insider activity, market movers and mergers & acquisitions.
In the last 30 days, CNK insiders filed 4 SEC Form 4 transactions — no purchases and 4 sales ($10.8M). The most active reporter was Gamble Sean, Chief Executive Officer, with 2 filings. 100% of those filings were made under pre-arranged Rule 10b5-1 plans.
Insider sale may signal reduced confidence, but size is modest relative to market cap.
The upcoming insider sale could modestly increase float and exert slight downward pressure on CNK price.
Potential modest upside if the box‑office momentum sustains; downside risk if attendance wanes.
Insider sell may signal confidence concerns, but size is modest relative to market cap.
Heavy buying and strong operating news could push the stock higher in the short term.
alphai scores every news story that mentions CNK with an AI model for sentiment and relevance, and aggregates insider trades from Cinemark Holdings, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Cavalier Michael (EVP-General Counsel) sold (to issuer) 107,296 indirectly-held shares of Cinemark Holdings, Inc. (CNK) at $35.02 ($3.76M total) on 2026-09-01 under a Rule 10b5-1 trading plan.
2 min readCinemark (CNK) officer Michael Cavalier plans to sell 107,296 shares, valued at $3.8M, via the Cavalier Revocable Trust. The shares stem from equity awards granted between 2014 and 2025, according to a Rule 144 notice. Cinemark has 115.9M shares outstanding as of September 1, 2026.
1 min readCinemark Holdings (CNK) reported record box office results for Spider-Man: Brand New Day, with strong premium format and in-theater spending. The company's stock has seen recent declines but remains up 17.61% over 90 days and 41.20% over one year. Analysts estimate CNK is 6.2% undervalued, with a fair value of $38.36, citing strong consumer demand and a robust film release pipeline.
2 min readGamble Sean (Chief Executive Officer) sold (to issuer) 138,884 indirectly-held shares of Cinemark Holdings, Inc. (CNK) at $38.19 ($5.30M total) on 2026-08-24 under a Rule 10b5-1 trading plan.
1 min readCinemark Holdings (CNK) shares rose due to institutional buying, with Barrow Hanley Mewhinney & Strauss LLC acquiring 246,000 shares. The surge follows record box office results from 'Spider-Man: Brand New Day' and Cinemark's first billion-dollar revenue quarter. Investors are optimistic about sustained growth, though debt and cash flow concerns remain.
1 min readAMC and Cinemark reported record Q2 earnings, with AMC's revenue up 14.2% and Cinemark's surpassing $1B. Both benefit from strong box office trends but face challenges like high costs and debt. AMC's leverage is above target, while Cinemark's performance depends on movie releases and rising electricity costs. Analysts expect strong growth for both, with Cinemark showing slightly better financial strength and growth prospects.
3 min readCinemark Holdings (CNK) reported record box office results for Spider-Man: Brand New Day, driving recent stock gains. The company's stock has risen 38.48% over 90 days, with a 1-year return of 39.64%. Analysts suggest CNK may be 5% undervalued, trading at $36.60 against a fair value of $38.36, citing strong consumer demand and a robust film release pipeline. However, risks include potential declines in theater attendance and revenue pressure from streaming services.
2 min readThomas Melissa (EVP, Chief Financial Officer) sold (to issuer) 38,236 shares of Cinemark Holdings, Inc. (CNK) at $37.53 ($1.43M total) on 2026-08-20 under a Rule 10b5-1 trading plan.
1 min readCinemark, a Texas-based theater operator, now supports the $110.8B Paramount-Warner Bros. Discovery merger, citing benefits for the box office and industry. AMC and Regal also back the deal, but California and the WGA oppose it, with a trial set for 2027.
2 min readCinemark, the third major U.S. theater chain, endorsed the $111 billion Paramount/Warner Bros. merger, supporting CEO David Ellison's promise of 30 films annually and a 45-day VOD wait. AMC and Regal previously endorsed the deal. Cinema United, a lobby group, opposes the merger due to antitrust concerns, and the court case is delayed until 2027.
2 min read
